The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. This vulnerability allows the application to accept manual entry of any active directory (AD) account provisioned in the application without supplying a password, resulting in access to the application as the supplied AD account, with all associated privileges.
References
| Link | Resource |
|---|---|
| https://www.cisa.gov/uscert/ics/advisories/icsma-21-343-01 | Mitigation Third Party Advisory US Government Resource |
Configurations
Configuration 1 (hide)
|
Configuration 2 (hide)
| AND |
|
Configuration 3 (hide)
| AND |
|
Configuration 4 (hide)
| AND |
|
Information
Published : 2021-12-15 19:15
Updated : 2022-07-25 10:39
NVD link : CVE-2021-43935
Mitre link : CVE-2021-43935
JSON object : View
Products Affected
baxter
- welch_allyn_connex_cardio
- welch_allyn_q-stress_cardiac_stress_testing_system
- welch_allyn_q-stress_cardiac_stress_testing_system_firmware
- welch_allyn_rscribe_resting_ecg_system
- welch_allyn_hscribe_holter_analysis_system_firmware
- welch_allyn_hscribe_holter_analysis_system
- welch_allyn_xscribe_cardiac_stress_testing_system_firmware
- welch_allyn_vision_express_holter_analysis_system
- welch_allyn_xscribe_cardiac_stress_testing_system
- welch_allyn_diagnostic_cardiology_suite
CWE
CWE-287
Improper Authentication
